Investigational drug · Phase 3
YHR2402
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Acute Bronchitis.
Phase 3Last checked: Nov 19, 2026Latest source record: Feb 9, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
1
0 still active
All registered trials
2
Any phase or sponsor naming "YHR2402"
First trial start
2025
Aug 19, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "YHR2402", any sponsor or status.
Conditions studied
As listed on its trial records.
- Acute Bronchitis
Largest trials
Live from ClinicalTrials.gov: studies naming "YHR2402" as an intervention, largest first.
- Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute BronchitisPivotal-lookingCompleted
Yuhan CorporationIndustry
NCT07111468 · 286 participants · Start Aug 19, 2025 · Primary completion Jan 15, 2026
Drug: YHP2401; YHR2402 and 1 more · For: Acute Bronchitis
Sites: Bucheon-si, South Korea; Chuncheon, South Korea; Iksan, South Korea · 11 sites in all
Yuhan CorporationIndustry
NCT06623526 · 26 participants · Start Oct 4, 2024 · Primary completion Nov 6, 2024
Drug: YHR2402; YHR2402+YHR2403 · For: Healthy Volunteers
Sites: Jeonju, South Korea
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Acute Bronchitis
- RaphaminMMH-407Phase 35 trials
Materia Medica Holding · Rhinosinusitis, Rhinosinusitis Acute, Cystitis Chronic
- AG2001Phase 31 trial
Ahn-Gook Pharmaceuticals Co.,Ltd · Acute Bronchitis
- AG20011Phase 31 trial
Ahn-Gook Pharmaceuticals Co.,Ltd · Acute Bronchitis
- AG20012Phase 31 trial
Ahn-Gook Pharmaceuticals Co.,Ltd · Acute Bronchitis
- DW5121Phase 31 trial
Daewon Pharmaceutical Co., Ltd. · Acute Bronchitis
- DW51211Phase 31 trial
Daewon Pharmaceutical Co., Ltd. · Acute Bronchitis
- DW51212Phase 31 trial
Daewon Pharmaceutical Co., Ltd. · Acute Bronchitis
- YHP2401Phase 31 trial
Yuhan Corporation · Acute Bronchitis
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.